THV Summit 2022

Published: 10 January 2023

  • Views:

    Views Icon 544

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

For this 2nd edition of the THV Summit, which was hosted in Amsterdam on (30 June - 1 July 2022) distinguished chair and faculty members present a full day of live cases from two renowned TAVI centres in EMEA for a case-based program dedicated to Aortic Valve Therapies.

 

During the THV Summit, experienced structural heart valve provided expert insight into the essentials of the TAVI procedure with two live cases. Each case focuses on a specific topic and patient profile using a step-by-step approach to review in detail the key factors to optimising valve therapy from pre-procedural planning to outcomes with special emphasis on efficiency and lifetime management of patients.

This meeting was supported by Boston Scientific

More from this programme

Part 1

CATHLAB LIVE

Managing complex cases – Obtaining procedural success and securing future options.
7 sessions
Introduction to the day Watch now
Case 1 – Karolinska University – TAVI in a Small Anatomy – Presentation Watch now
Case 1 – Karolinska University – TAVI in a Small Anatomy – Panel Discussion Watch now
Case 1 – Karolinska University – TAVI in a Small Anatomy – Live Case Watch now
Case 2 – Kerckhoff Heart Center – TAVI in Challenging Femoral Access – Introduction Watch now
Case 2 – Kerckhoff Heart Center – TAVI in Challenging Femoral Access – Panel Discussion Watch now
Case 2 – Kerckhoff Heart Center – TAVI in Challenging Femoral Access – Live Case Watch now

Faculty Biographies

Lars Søndergaard

Lars Søndergaard

Professor Lars Søndergaard is a consultant cardiologist at Rigshospitalet – Copenhagen, Denmark. Professor of Cardiology at University of Copenhagen, he published over 300 peer reviewed articles, and more than 15 textbook chapters. His research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions, as well as congenital and structural heart diseases. He led the first-in-human transcatheter mitral valve implantation (CardiAQ) in 2012 and he actively participated to several trials, including NOTION (transcatheter vs. surgical aortic valve replacement in patients with aortic stenosis and low surgical risk), and the REDUCE randomised trial (PFO vs anti-platelet therapy after cryptogenic stroke).

View full profile
Darren Mylotte

Darren Mylotte

Consultant Cardiologist

Dr Darren Mylotte graduated from RCSI Medical School in 2001, obtained membership of the Royal College of Physicians in Ireland in 2004, and completed the Irish Cardiology Specialist Training Scheme. He and was conferred with a Doctor of Medicine (MD) thesis in 2010 by the Royal College of Surgeons in Ireland and has also undertaken a PhD thesis. N the subject of Transcatheter Aortic Valve Implantation (TAVI) at the world renowned ThoraxCentre in Rotterdam, The Netherlands.

 

View full profile
Marek Grygier

Marek Grygier

Poznan University of Medical Sciences, Poznan, Poland

View full profile
Andreas Rück

Andreas Rück

Dr Andreas Rück is the head of the Transcatheter Aortic Valve Implantation (TAVI) program at Karolinska University Hospital – Stockholm, Sweden and the chairman of the Swedish Percutaneous Valve Registry (a registry within the Swedish Heart Registries SWEDEHEART). He is member of the steering group of SWEDEHEART and of the Working group for PCI and Valve Interventions within the Swedish Society of Cardiology. His clinical specialties include PCI and percutaneous valve implantation.

View full profile